20% of Big 4-audited IPOs report weaknesses in financial-reporting controls
Market Watch published a piece about an SEC proposal to exempt some development-stage biotech and medical device companies from getting an auditor’s opinion on their internal controls. Commissioner Hester Peirce spoke of her support for the proposal at Mendoza's 2019 CARE conference, saying that investors want their money to go to research and growing the company and not to auditors.
- Published
Related News & Stories
Alumni Impact
EMBA alumni return, reconnect, grow
Graduates spanning decades shared experiences and left with fresh ideas.
Speakers and Conferences
Blackstone’s Sean Klimczak on AI, leadership and the future of infrastructure
Five takeaways from the first Dean’s Speaker Series event of 2026-2027.
Alumni Impact
Speed networking pairs alumni, students
Notre Dame held its first Executive Connections, a speed networking event that brought 24 alumni executives to campus to meet MBA and Specialized Master’s students.